Antibiotic combinations: the clinical relevance of synergy and antagonism.
D000617:Aminoglycosides / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D002701:Chloramphenicol / Q000627:therapeutic use; D004336:Drug Antagonism; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013754:Tetracyclines / Q000627:therapeutic use
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D010406:Penicillins; D011113:Polymyxins; D013449:Sulfonamides; D013754:Tetracyclines; D004917:Erythromycin; D002701:Chloramphenicol; D008034:Lincomycin